ANAVIP
NDC 66621-0790, crotalidae immune F(ab)2(equine), injection, powder, lyophilized, for solution, from Rare Disease Therapeutics, Inc.
- Product NDC
- 66621-0790
- Status
- Listed
- Labeler
- Rare Disease Therapeutics, Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125488
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66621-0790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)12 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66621-0790-2 | 66621079002 | 1 VIAL in 1 CARTON (66621-0790-2) / 10 mL in 1 VIAL (66621-0790-1) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=66621-0790
Use it
Look up 66621-0790 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66621-0790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66621-0790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.